Human normal immunoglobulin G is indicated for:
Population group: only minors (0 - 18 years old) , adults (18 - 65 years old)
Replacement therapy in adults, children and adolescents (0-18 years) in:
* PSAF = failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal polysaccharide and polypeptide antigen vaccines.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only minors (0 - 18 years old) , adults (18 - 65 years old)
Immunomodulatory therapy in adults, children and adolescents (0-18 years):
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Human normal immunoglobulin G is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.